Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nickolas Papadopoulos

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Science (New York, N.Y.)|March 2, 2021
Targeting a neoantigen derived from a common <i>TP53</i> mutationEmily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
Nature|March 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancersTushar D Nichakawade, Jiaxin Ge, Brian J Mog, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
Science (New York, N.Y.)|July 2, 2011
Altered telomeres in tumors with ATRX and DAXX mutationsChristopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, et al.
Science Immunology|March 2, 2021
Bispecific antibodies targeting mutant <i>RAS</i> neoantigensJacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Science (New York, N.Y.)|March 2, 2021
Targeting a neoantigen derived from a common <i>TP53</i> mutationEmily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
Nature|March 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancersTushar D Nichakawade, Jiaxin Ge, Brian J Mog, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.
Science (New York, N.Y.)|July 2, 2011
Altered telomeres in tumors with ATRX and DAXX mutationsChristopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, et al.
Science Immunology|March 2, 2021
Bispecific antibodies targeting mutant <i>RAS</i> neoantigensJacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog, et al.
Pageof 19